drugset / Trial / NCT01610154

Contribution of Pancreatic αcells Function to Blood Glucose Regulation in Chinese Type 2 Diabetics- the Effect of Sitagliptin on Glucagon Secretion, Insulin Secretion and Insulin Resistance in Chinese Type 2 Diabetics

NCT01610154

Phase 4 Completed 85 enrolled Guangwei Li
NaSingle-groupOpen-labelTreatment

Summary

1. The purpose of this study is to determine whether Sitagliptin therapy suppress glucagon release and improve glucose control in Chinese type 2 diabetic. 2. There are different effects of Sitagliptin therapy on blood glucose regulation, pancreatic alpha \& beta cell function are different in lean (BMI\<25) and overweight (BMI\>25) Chinese type 2 diabetics. 3. The purpose of this study is to determine whether glucagon release may contribute over 30% to the hyperglycemia in Chinese type 2 diabetics.

Timeline

Start
2012-10
Primary completion
2014-08
Completion
2015-06

Drugs

EvaluationDrugModalityDoseRoute
Subject Sitagliptin Small molecule 100 mg